ABC12: New drug kills metastatic melanoma

UC research looks at new drug that could improve treatments for metastatic melanoma

Doctors can often detect and treat early-stage melanoma, but when it advances, it is much tougher to fight and is fatal nearly half the time. Now a team of scientists at the University of Cincinnati is developing a combination therapy that can improve existing melanoma treatments.

Years of sun exposure or other UV light is a risk factor for melanoma, which can be deadly if not caught early.

“Melanoma, eventually, tends to go to the brain,” described Soma Sengupta, MD, PhD, a neuro-oncologist at the University of Cincinnati and UC Health.

“When it goes to the brain, it’s extremely challenging to treat,” explained Daniel Pomeranz Krummel, PhD, a researcher at the University of Cincinnati.

Watch the full ABC12 report.

Read more about this research on UC News.

Featured photo of Pomeranz Krummel and Sengupta in their lab by Joe Fuqua/UC Creative + Brand.

Impact Lives Here

The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.

Stay up to date on all UC's COVID-19 stories, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.